190 related articles for article (PubMed ID: 15192803)
1. HBV infection in patients with end-stage renal disease.
Fabrizi F; Bunnapradist S; Martin P
Semin Liver Dis; 2004; 24 Suppl 1():63-70. PubMed ID: 15192803
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A
Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection: implications in chronic kidney disease, dialysis and transplantation.
Ayodele OE; Salako BL; Kadiri S; Arije A; Alebiosu CO
Afr J Med Med Sci; 2006 Jun; 35(2):111-9. PubMed ID: 17209304
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection and the dialysis patient.
Fabrizi F; Messa P; Martin P
Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis and HIV infection during haemodialysis.
Saha D; Agarwal SK
J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
[TBL] [Abstract][Full Text] [Related]
6. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis B virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):397-402. PubMed ID: 20198898
[TBL] [Abstract][Full Text] [Related]
8. Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.
Filik L; Karakayali H; Moray G; Dalgiç A; Emiroğlu R; Ozdemir N; Colak T; Gür G; Yilmaz U; Haberal M
Transplant Proc; 2006 Mar; 38(2):496-8. PubMed ID: 16549158
[TBL] [Abstract][Full Text] [Related]
9. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
Kim JA; Huh W; Lee KW; Kim SJ; Kim YG; Kim DJ; Joh JW; Oh HY
Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection in hemodialysis: recent discoveries.
Fabrizi F; Lunghi G; Martin P
J Nephrol; 2002; 15(5):463-8. PubMed ID: 12455711
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
Wang SS; Chou NK; Chi NH; Hsu RB; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Lai MY; Chu SH
Transplant Proc; 2006 Sep; 38(7):2138-40. PubMed ID: 16980024
[TBL] [Abstract][Full Text] [Related]
12. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B in children.
Broderick AL; Jonas MM
Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451
[TBL] [Abstract][Full Text] [Related]
14. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
Kes P; Slavicek J; Janković N
Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
16. [Natural history of HBV in dialysis population].
Fabrizi F; Martin P; Lunghi G; Ponticelli C
G Ital Nefrol; 2004; 21(1):21-8. PubMed ID: 15356843
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
[TBL] [Abstract][Full Text] [Related]
18. Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation.
Kranz B; Vester U; Bonzel KE; Paul A; Gerken G; Hoyer PF
Pediatr Transplant; 2006 May; 10(3):384-9. PubMed ID: 16677367
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus infection in dialysis patients.
Wong PN; Fung TT; Mak SK; Lo KY; Tong GM; Wong Y; Loo CK; Lam EK; Wong AK
J Gastroenterol Hepatol; 2005 Nov; 20(11):1641-51. PubMed ID: 16246180
[TBL] [Abstract][Full Text] [Related]
20. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
